| MYST3-CREBBP rearrangement harbors a distinctive microRNA signature targeting RET proto-oncogene in acute myeloid leukemia with translocation (8;16)(p11;p13). | leukemia, |
| KAT6A, a chromatin modifier from the 8p11-p12 amplicon is a candidate oncogene in luminal breast cancer. | breast, |
| These data suggest that KAT6A may be a novel oncogene in breast cancers bearing the 8p11-p12 amplicon. | breast, |
| MOZ-TIF2 oncogenic fusion protein suppresses transcription by nuclear receptors and p53 | None |